auto_awesome
Tracking this entity every week?
Watch this entity, get an email digest the moment they win, lose, or are recompete-eligible. Free on every plan.
Industrial Research Assistance Program – Contributions to Firms
FollowEmail alerts on new grants under this program
Total Grants
26,775
Total Amount
$5.1B
Provinces Served
13
Top Recipients by Funding Amount
| # | Recipient | Grants | Total Amount |
|---|---|---|---|
| 1 | Entos Pharmaceuticals Inc. | 15 | $62.2M |
| 2 | Laurent Pharmaceuticals Inc. | 11 | $53.8M |
| 3 | Pharma Glycovax Inc | 10 | $53.6M |
| 4 | Providence Therapeutics Holdings Inc. | 7 | $46.5M |
| 5 | Qu Biologics Inc. | 19 | $35.7M |
| 6 | ImmunoVaccine Technologies Inc. | 8 | $24.7M |
| 7 | Corvus Energy Inc. | 4 | $23.6M |
| 8 | Symvivo Corporation | 6 | $22.4M |
| 9 | JN NOVA PHARMA INC | 4 | $18.4M |
| 10 | AbCellera Biologics Inc. | 4 | $17.5M |
| 11 | Mannin Research Inc | 5 | $17.4M |
| 12 | In-Sec-M, Security Research and Innovation | 10 | $16.5M |
| 13 | Trulioo Information Services Inc. | 6 | $16.1M |
| 14 | Octopusapp Inc. | 8 | $16.0M |
| 15 | Vention inc. | 3 | $15.8M |
| 16 | Solace Corporation | 3 | $14.0M |
| 17 | HyperMabs Inc. | 6 | $12.8M |
| 18 | Sanotize Research and Development Corp. | 3 | $12.1M |
| 19 | Intellectual Property Institute of Canada | 9 | $11.6M |
| 20 | Macrodyne Technologies Inc. | 6 | $11.6M |
Geographic Distribution by Province
| Province / Territory | Grants | Total Amount | Share |
|---|---|---|---|
| ON | 7,542 | $1.4B | 28% |
| QC | 5,993 | $1.2B | 25% |
| BC | 4,985 | $910.6M | 18% |
| AB | 3,046 | $630.1M | 12% |
| NS | 1,202 | $218.2M | 4% |
| NL | 875 | $152.1M | 3% |
| MB | 949 | $148.6M | 3% |
| NB | 881 | $140.3M | 3% |
| SK | 845 | $136.9M | 3% |
| PE | 374 | $59.5M | 1% |
| NU | 38 | $6.6M | 0% |
| NT | 16 | $2.5M | 0% |
| YT | 29 | $2.5M | 0% |
Recent Grants
Recipient
Amount
Year
Purpose
WOLF Advanced Technology Canada Inc.
$10.0M
--
Entos Pharmaceuticals Inc.
$10.0M
--
Macrodyne Technologies Inc.
$10.0M
--
Entos Pharmaceuticals Inc.
$10.0M
--
Providence Therapeutics Holdings Inc.
$10.0M
--
Entos Pharmaceuticals Inc.
$10.0M
--
ILLUMIN INC.
$10.0M
--
Entos Pharmaceuticals Inc.
$10.0M
--
Laurent Pharmaceuticals Inc.
$10.0M
--
Solace Corporation
$10.0M
--
Laurent Pharmaceuticals Inc.
$10.0M
--
Providence Therapeutics Holdings Inc.
$8.7M
--
Providence Therapeutics Holdings Inc.
$8.6M
--
Pharma Glycovax Inc
$8.5M
--
Pharma Glycovax Inc
$8.1M
--
Pharma Glycovax Inc
$8.1M
--
Pharma Glycovax Inc
$8.1M
--
Vention inc.
$7.7M
--
Vention inc.
$7.7M
--
Laurent Pharmaceuticals Inc.
$7.0M
--
Laurent Pharmaceuticals Inc.
$7.0M
--
Northern RNA Inc.
$7.0M
--
Laurent Pharmaceuticals Inc.
$7.0M
--
NORTHERN RNA INC.
$7.0M
--
WOLF Advanced Technology Canada Inc.
$10.0M--
WOLF Advanced Technology Canada Inc. will develop a new generation of rugged, high performance embedded computing module...
Entos Pharmaceuticals Inc.
$10.0M--
Entos has developed Covigenix VAX-001, a DNA Proteo-Lipid Vehicle (PLV) vaccine intended for the prevention of COVID-19 ...
Macrodyne Technologies Inc.
$10.0M--
Development of advanced superplastic forming technology which uses Gas Oscillation to drastically (up to 10x) increase t...
Entos Pharmaceuticals Inc.
$10.0M--
Entos has developed Covigenix VAX-001, a DNA Proteo-Lipid Vehicle (PLV) vaccine intended for the prevention of COVID-19 ...
Providence Therapeutics Holdings Inc.
$10.0M--
Providence Therapeutics intends to continue the clinical development of a made-in-Canada mRNA vaccine against COVID-19. ...
Entos Pharmaceuticals Inc.
$10.0M--
Entos has developed Covigenix VAX-001, a DNA Proteo-Lipid Vehicle (PLV) vaccine intended for the prevention of COVID-19 ...
ILLUMIN INC.
$10.0M--
Research and development of an omni-channel advertising platform and internal business processes designed specifically t...
Entos Pharmaceuticals Inc.
$10.0M--
Entos has developed Covigenix VAX-001, a DNA Proteo-Lipid Vehicle (PLV) vaccine intended for the prevention of COVID-19 ...
Laurent Pharmaceuticals Inc.
$10.0M--
Clinical development of LAU-7b antiviral and inflammation-controlling therapy for COVID-19 infection.
Solace Corporation
$10.0M--
A project to create an event-enabled, edge-supporting, integration and API management platform that supports modern, rea...
Laurent Pharmaceuticals Inc.
$10.0M--
Clinical development of LAU-7b antiviral and inflammation-controlling therapy for COVID-19 infection.
Providence Therapeutics Holdings Inc.
$8.7M--
The Firm is Canada's leader in mRNA therapeutics and this project's main goal is to continue the development of PTX-COVI...
Providence Therapeutics Holdings Inc.
$8.6M--
The Firm is Canada's leader in mRNA therapeutics and this project's main goal is to continue the development of PTX-COVI...
Pharma Glycovax Inc
$8.5M--
Using O-glycan biomarkers, a vaccine against Covid-19 virus will be confirmed as non-toxic and then tested at the clinic...
Pharma Glycovax Inc
$8.1M--
Using O-glycan biomarkers, a vaccine against Covid-19 virus will be confirmed as non-toxic and then tested at the clinic...
Pharma Glycovax Inc
$8.1M--
Using O-glycan biomarkers, a vaccine against Covid-19 virus will be confirmed as non-toxic and then tested at the clinic...
Pharma Glycovax Inc
$8.1M--
Using O-glycan biomarkers, a vaccine against Covid-19 virus will be confirmed as non-toxic and then tested at the clinic...
COVEO SOLUTIONS INC.
$8.0M--
This project aims to offer personalized services and recommendations.
Vention inc.
$7.7M--
Build & Operate will create the software necessary to automate production using a number of third-party collaborative ro...
Vention inc.
$7.7M--
Build & Operate will create the software necessary to automate production using a number of third-party collaborative ro...
Laurent Pharmaceuticals Inc.
$7.0M--
The project is focusing on Phase 3 pivotal study of LAU-7b in moderate-to-severe hospitalized COVID-19 patients, and has...
Laurent Pharmaceuticals Inc.
$7.0M--
The project is focusing on Phase 3 pivotal study of LAU-7b in moderate-to-severe hospitalized COVID-19 patients, and has...
Northern RNA Inc.
$7.0M--
The COVID-19 pandemic has impacted the global supply of nucleic acid products including mRNA and plasmid DNA and deliver...
Laurent Pharmaceuticals Inc.
$7.0M--
The project is focusing on Phase 3 pivotal study of LAU-7b in moderate-to-severe hospitalized COVID-19 patients, and has...
NORTHERN RNA INC.
$7.0M--
The COVID-19 pandemic has impacted the global supply of nucleic acid products including mRNA and plasmid DNA and deliver...
Explore More Government Data
IT Spending by Department
Federal technology budgets and consulting spend trends
Departmental Budgets
Budget breakdowns for every federal department and agency
Federal Contracts
Search 1.3M+ government contracts from the Open Government Portal
Contract Awards
Track who wins government contracts and award patterns
Standing Offers
Browse TBIPS, ProServices, and other procurement vehicles
Buy Canadian Policy
Guide to the 2025-2026 domestic procurement policy
Indigenous Procurement
PSAB, mandatory set-asides, and the 5% target